Does Amniotic Fluid Index Affect the Fetal Cardiac Performance?

NCT03277417 — Unknown, 90 participants, Hillel Yaffe Medical Center

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Does the Amniotic Fluid Index Affect the Fetal Cardiac Performance?

Registry	NCT03277417
Status	Unknown
Study type	Observational
Enrollment	90 (Estimated)
Sponsor	Hillel Yaffe Medical Center (Other gov)
Conditions	Oligohydramnios, Polyhydramnios
Interventions	Echocardiography (Other)
Dates	start 2017-09-01 (estimated), primary completion 2019-09-01 (estimated), completion 2019-09-01 (estimated), first posted 2017-09-11, last updated 2017-09-11
Locations	1 site in Israel

-Summary

To evaluate and compare fetal cardiac performance by fetal echocardiography and delivery outcome between fetuses with isolated oligohydramnios, normal amniotic fluid and polyhydramnios.

Expand all sections · Collapse all

+Arms and interventions

Arm	Interventions	Description
Isolated Oligohydramnios	Other: Echocardiography	Fetuses with amniotic fluid index (AFI) equal or less than 5 cm
Isolated Polyhydramnios	Other: Echocardiography	Fetuses with amniotic fluid index (AFI) more than 25 cm
Control Group	Other: Echocardiography	Fetuses with normal amount of amniotic fluid

Echocardiography (Other): Imaging of fetal heart and amniotic fluid

+Outcome measures

Primary outcomes

Fetal cardiac ventricles [One month]: The width of the fetal cardiac ventricles will be measured and compared between all three groups

Secondary outcomes

Gestational age [One month]: Gestational age at delivery will be compared between the three groups
Mode of delivery [One month]: Mode of delivery will be compared between the three groups
Birth weight [One month]: Birth weight will be compared between the three groups

+Eligibility

Sex: Female, ages: 18 Years to any

Inclusion Criteria:

* Gestational age 24-42 weeks
* Singleton pregnancies

Exclusion Criteria:

* Fetal anatomical or chromosomal abnormality
* Known fetal cardiac defect
* Suspected fetal infection
* Suspected IUGR

+Locations (1)

Facility	City	Country	Status
Hillel Yaffe Medical Center	Hadera	Israel

+Investigators

Rinat Gabbay-Benziv, MD, Principal investigator, Hillel Yaffe Medical Center